Premium
Controversy: Are Systemic Steroids Indicated in the Treatment of Erythema Multiforme?
Author(s) -
Renfro Lisa,
GrantKels Jane M.,
Feder Henry M.,
Daman Lauren A.
Publication year - 1989
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/j.1525-1470.1989.tb00266.x
Subject(s) - erythema multiforme , medicine , dermatology , erythema , disease , systemic therapy , systemic disease , intensive care medicine , cancer , breast cancer
The treatment of erythema multiforme major with systemic steroids became established during the 1950s. Recently, two retrospective case reviews comparing steroid‐treated and nonsteroid‐treated groups of patients with erythema multiforme found that these agents may be associated with complications. As a result, many clinicians have become uncertain as to the appropriate therapy of this disease entity. We successfully treated the condition with steroids in two children and one adolescent. The controversy over the potential efficacy of such therapy for erythema multiforme persists, however.